Risk Factors for Persistent Atrial Fibrillation Following Successful Hyperthyroidism Treatment with Radioiodine Therapy
| Autor: | Long-Le Ma, Lexin Wang, Zhen-Hu Zhou |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Adult
Male medicine.medical_specialty Logistic regression Hyperthyroidism Iodine Radioisotopes Ventricular Dysfunction Left Risk Factors Internal medicine Lv dysfunction Atrial Fibrillation Internal Medicine medicine Humans Aged Paroxysmal AF Ejection fraction business.industry Atrial fibrillation Radioiodine therapy General Medicine Middle Aged medicine.disease Echocardiography Persistent atrial fibrillation Cardiology Female business Holter monitoring |
| Zdroj: | Internal Medicine. 50:2947-2951 |
| ISSN: | 1349-7235 0918-2918 |
| DOI: | 10.2169/internalmedicine.50.6135 |
| Popis: | Objective To investigate the predicting factors for persistent atrial fibrillation (AF) following radioiodine therapy for hyperthyroidism. Methods Standard 12-lead ECG and 24-h Holter monitoring were performed in 94 patients (38 males, mean age 46.1±8.2 years) with persistent AF following radioiodine therapy for hyperthyroidism. Left ventricular (LV) function was assessed with two-dimensional echocardiography. Results Euthyroidism or hypothyroidism was achieved in 81% and 19% of the patients, respectively, after radioiodine therapy. At the end of follow-up (1.6±1.3 years), LV ejection fraction in the 52 patients with LV dysfunction was increased from 39.3±3.3% to 59.0±5.5% (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|